DEF 14A

Company

Immunome Inc.

Filed

April 20, 2023

Period of Report

June 7, 2023

Accession Number

0001104659-23-047884

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →